LRP5 and neoplasm: This immunostimulatory pattern was markedly reduced when LIMA1 was knocked down, suggesting that LIMA1 may contribute to the pro-inflammatory, anti-tumor immune microenvironment induced by LRP5-overexpressing osteocyte-derived CM.